myopia
Conditions
Interventions
Subjects will be treated with a Myopia Management Devices (Eyerising International, South Yarra VIC, Australia) 5 days a week, three minutes per session, twice a day, with a minimum interval of 4 hour
Sponsors
Institute of Science Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Age: 6 to 12 years at enrolment 2) Myopia: Cycloplegic SER -1.0 to -7.0 diopters (D) in each eye 3) Anisometropia : < 1.5 D 4) Astigmatism: < 1.5 D 5) Best corrected visual acuity (BCVA) 20/25 or better. 6) Informed parental consent
Exclusion criteria
Exclusion criteria: 1) Ophthalmic diseases, conditions, or syndromes other than ammetropia and myelinated nerve fiber layer, or prematurity (less than 36 weeks of gestation) 2) Previous use of optical or pharmacologic treatment for myopia control (e.g., defocusing spectacle or contact lenses, orthokeratology, atropine, or pirenzepine) 3) Systemic diseases (e.g., endocrine, cardiac diseases) and developmental anomalies 4) Inability to attend regular follow up visits
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in cycloplegic SER Changes in AL | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the rate of SER and AL increase Changes in other biometric parameters except AL: ACD, CC, WTW, CT and choroidal structures. Best corrected visual acuity (BCVA), intraocular pressures, ocular and systemic symptoms, ocular signs assessed by slit lamp biomicroscopy and binocular indirect ophthalmoscopy, and questionnaire for self-reported visual function Pupil size in room light measured by pupillometer (option) | — |
Countries
Japan,Asia(except Japan),North America
Contacts
Public ContactHiroyuki Takahashi
Institute of Science Tokyo Ophthalmology
Outcome results
None listed